Welcome to the 2nd Annual Computational RNA Design & Delivery Summit!
TURBOCHARGING EFFICACIOUS RNA MEDICINES WITH THE POWER OF ARTIFICIAL INTELLIGENCE
Returning for the 2nd year, the Computational RNA Design & Delivery Summit is the only industry-led meeting of its kind dedicated to congregating the most forward thinking biotechs, established large pharma, and key academic opinion leaders committed to training and validating machine learning and artificial intelligence algorithms to accelerate design and delivery of mRNA, siRNA, gRNA and beyond with improved efficacy and specificity.
Following Nobel Prize recognition in 2024, and huge collaborations such as that between Moderna and OpenAI as well as Gensaic and Novo Nordisk, computational approaches such as artificial intelligence and machine continue to dominate large investments and partnerships within the RNA community - highlighting their promise for driving more therapeutically relevant RNAs towards the clinic.
Join Sanofi, Strand Therapeutics, CSL Seqirus, and many others for the ultimate opportunity to hear scientific, technical insights on AI and data science innovations for fast-tracking discovery of potent RNAs and new delivery chemistries for advancing efficacious medicines
towards approval.
WORLD-CLASS SPEAKER FACULTY INCLUDE:
18+
WORLD-CLASS SPEAKERS
12+
DATA DRIVEN PRESENTATIONS
6
DEEP DIVE DISCUSSIONS
70+
COMPUTATIONAL RNA EXPERTS
2
COMPREHENSIVE DAYS OF CONTENT
“A great opportunity to learn state-of-the-art techniques, access valuable datasets, explore collaboration opportunities, and expand the network.”
Sizhen Li, Computational Scientist Lead, Sanofi
“The greatest value of this meeting lies in gathering diverse experts with a shared focus on innovative solutions, particularly those that fuse advanced computational methods with experimental insight. By bringing together talented professionals facing similar technical and scientific challenges, we can foster deeper collaborations, spark new ideas, and accelerate breakthroughs in the mRNA therapeutics field.”
Frank Hidalgo, Senior Machine Learning Scientist, Strand Therapeutics
“Participating in this meeting offers a valuable opportunity to stay updated on the latest advancements in RNA design and delivery, including AI applications in both areas. It also provides a chance to foster collaborations with leading experts and contribute to shaping the future of the field.”
Lingtao Peng, Director, Head, Molecular, Cellular & Synthetic Biology, CSL Seqirus
2025 PARTNERS:
